AHFS Drug Information (AHFS DI) is a leading source of evidence-based drug information.

AHFS DI is a dependable, comprehensive and objective database for FDA approved drug products. Inclusion of evidence-based data on labelled and unlabelled drug use makes this a valuable reference for healthcare professionals seeking to provide their patients with safe and effective therapy.

AHFS DI is published by the American Society of Health-System Pharmacists (ASHP).

SubscribeContent Updates
Features and Benefits icon

Comprehensive: Highly detailed monographs with extensive information on the chemistry and clinical application of all FDA approved drugs

Features and Benefits icon

Evidence-based: Built on evidence from primary sources and peer reviewed by over 500 pharmacists, physicians and healthcare professionals

Features and Benefits icon

Dependable: Fast and easy access to content that is revalidated, revised and updated regularly as new information arrives

Features and Benefits icon

Objective: The information is compiled without any influence from manufacturers, insurers, regulators or other interested parties

Publication Updates

14 Aug
AHFS Drug Information logo
AHFS Drug Information August 2018 update

This update contains 6 new monographs and 15 revised monographs.

New monographs: Factor Xa (recombinant), Inactivated-zhzo; Erenumab-aooe; Avatrombopag; Pegvaliase; Baricitinib; Lofexidine

Revised monographs: Editorial Staff; Crizotinib; PONATinib; Ceritinib; Perampanel; Alectinib; Daclizumab; Avelumab; Durvalumab; Brigatinib; Sodium Nitroprusside; Mebendazole; Primaquine; Riluzole; Albendazole

10 Jul
AHFS Drug Information logo
AHFS Drug Information July 2018 update

This update contains 2 new monographs, 5 new MedWatch alerts and 95 revised monographs.

New monographs: Burosumab-twza, Fostamatinib.

Revised monographs: Dofetilide, Alosetron, Entacapone, Etanercept, miFEPRIStone, inFLIXimab, inFLIXimab-dyyb, Alemtuzumab, Minocycline, Clopidogrel, Tenofovir Disoproxil Fumarate, Bosentan, Doxycycline, Sodium Oxybate, Adalimumab, Emtricitabine, Natalizumab, Lenalidomide, Varenicline, Rasagiline, Ambrisentan, Lisdexamfetamine, Eculizumab, Alvimopan, romiPLOStim, Dronedarone, Tolvaptan, Golimumab, Tapentadol, Vigabatrin, Denosumab, Liraglutide, Fingolimod, Ustekinumab, Pegloticase, Collagenase Clostridium Histolyticum, Ipilimumab, Vandetanib, Belatacept, Apixaban, Tofacitinib, Teduglutide, PONATinib, Pomalidomide, Dolutegravir, Riociguat, Macitentan, Lomitapide, Mipomersen, Apremilast, Pembrolizumab, Idelalisib, Panobinostat, Parathyroid Hormone, Alemtuzumab, Blinatumomab, Alirocumab, Evolocumab, Flibanserin, Atezolizumab, idaruCIZUmab, Metreleptin, Daclizuma, Crisaborole, Oxymetazoline, Brodalumab, Deutetrabenazine, Midostaurin, Safinamide, Dolutegravir and Rilpivirine, HYDROcodone, ISOtretinoin, HYDROmorphone, oxyMORphone, oxycodone,Morphine, Methadone, Neomycin, Bacitracin, Levodopa/Carbidopa, Benzocaine, HYDROcodone, fentaNYL, Propranolol, Testosterone, Polymyxin B, MAO Inhibitors General Statement, Erythromycins General Statement, Insulin Human, Naltrexone, Buprenorphine, cloZAPine, OLANZapine, Selegiline, Rosiglitazone, Thalidomide.

Discontinued monographs: Insulin zinc.

New medwatch alerts on the following monographs: Dolutegravir, Dolutegravir and Rilpivirine, Benzocaine, Pembrolizumab, Atezolizumab.

11 Jun
AHFS Drug Information logo
AHFS Drug Information June 2018 update

This update contains 1 new monograph, 1 new MedWatch alert and 9 revised monographs.

New monograph: Ibalizumab-uiyk

Revised monographs: Chlorhexidine; Netupitant/Palonosetron, Deflazacort, Abaloparatide, Erythromycins General Statement, Extended-Spectrum Penicillins General Statement, Zidovudine, lamotrigine, lamivudine. 

14 May
AHFS Drug Information logo
AHFS Drug Information May 2018 update

This update contains 1 new monographs and 24 revised monographs.

New monograph: Bictegravir, Emtricitabine, and Tenofovir Alafenamide.

Revised monographs: Risedronate; Zoledronic Acid; Treprostinil; Teriparatide; Ibandronate; Tipranavir; Denosumab; Rucaparib; Dupilumab; Delafloxacin; ARIPiprazole Tablets with Sensor; Ergocalciferol; Etidronate; Calcium Salts; Calcitonin; Vitamin D Analogs General Statement; Extended-Spectrum Penicillins General Statement; Quinapril; Ciprofloxacin; Ofloxacin; Moexipril; Alendronate; Raloxifene; Perindopril.

10 Apr
AHFS Drug Information logo
AHFS Drug Information April 2018 update

This update contains 5 new monographs, 20 revised monographs and changes to MedWatch alerts for 3 monographs.

New monographs: ARIPiprazole Tablets with Sensor; Angiotensin II; Lutetium Lu 177 Dotatate; Tezacaftor and Ivacaftor; Apalutamide.

Revised monographs: Copyrights; Editorial Staff; Candesartan; Olmesartan; Gefitinib; Sofosbuvir; Albiglutide; Dulaglutide; Selexipag; Obeticholic Acid; Insulin Degludec;

Deoxycholic Acid; Avelumab; Loperamide; Corticosteroids General Statement; Ketorolac; Clarithromycin; Losartan; buPROPion; Irbesartan.

MedWatch Alerts: Loperamide; Clarithromycin; Obeticholic Acid.